Meeting
2020 ASCO Virtual Scientific Program
Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens.
Authors
Di Ran
HTG Molecular Diagnostics, Tucson, AZ
Di Ran , Janhavi Moharil , James Lu , Heather Gustafson , Kerry Culm-Merdek , Kristen Strand-Tibbitts , Laura Benjamin , Marian Navratil
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3566)
DOI
10.1200/JCO.2020.38.15_suppl.3566
Abstract #
3566
Poster Bd #
296
Abstract Disclosures
Similar Posters
First Author: Scott Mattox Haake
Poster
2016 Genitourinary Cancers Symposium
Impact of therapy on gene expression in high-risk prostate cancer (PCA) treated with neoadjuvant docetaxel and androgen deprivation therapy.
First Author: Himisha Beltran
Poster
2023 ASCO Breakthrough
Predicting response of gemcitabine plus cisplatin chemotherapy using RNA sequencing in patients with advanced urothelial carcinoma.
First Author: Kwonoh Park
Poster
2023 ASCO Annual Meeting
Biomarker-driven prospective clinical trial in renal cell carcinoma: Developing machine learning models to allocate patients to treatment arms using RNA sequencing.
First Author: Anupama Reddy